Background: Skeletal muscle can experience pronounced metabolic adaptations in response to extrinsic stimuli, and expresses leptin receptor (OB-Rb). We aimed to further the understanding of leptin effects on muscle cells, by studying the expression of key energy metabolism genes in C2C12 myotubes. Methods: We performed a dose-time-dependent study with physiological concentrations of leptin: 5, 10 and 50ng/ml, for 0, 30', 3h, 6h, 12h and 24h, also monitoring time-course changes in non-treated cells. mRNA levels were analyzed by RT-qPCR and peroxisome proliferator activated receptor γ coactivator 1α (PGC1α) protein levels by western blot. Results: The most significant effects were observed with 50ng/ml leptin. In the short-term (30' and/or 3h), leptin significantly induced the expression of PGC1α, muscle carnitine palmitoyl transferase 1 (mCPT1), uncoupling protein 3 (UCP3), OB-Rb, Insulin receptor (InsR) and interleukins 6 and 15 (IL6, IL15). There was a decrease in mRNA levels of pyruvate dehydrogenase kinase 4 (PDK4) and mCPT1 in the long-term (24h). PGC1α protein levels were increased (24h). Conclusion: Leptin rapidly induces the expression of genes important for its own response and the control of metabolic fuels, with the rapid responses of the genes encoding the master regulator PGC1α, mCPT1, UCP3, PDK4 and the signaling secretory molecule IL6 particularly interesting.
Introduction
Skeletal muscle has a high impact on energy metabolism in mammals, and exercise has been associated with improvements in sensitivity to the main metabolic hormones such as insulin and leptin [1, 2] . Leptin is a hormone/adipokine, mainly produced by adipose tissue in proportion to fat mass, which regulates energy metabolism; it can decrease food intake and increase energy expenditure, both by communicating energy status to the brain (and thereby activating key signaling pathways) and by direct peripheral mechanisms, although it is also able to regulate several other processes such as immunity, glucose and lipid metabolism, reproduction, etc. [3] . The long isoform of the leptin receptor (OB-Rb) has been proposed as the only one with full-signaling capacity and is expressed in a wide range of tissues, with notable expression in hypothalamus and skeletal muscle [3, 4] . Leptin can activate several intracellular signaling pathways [4] , and one of the main pathways involves JAK/STAT kinases/transcription factors [3] ; by this same pathway leptin is able to control its own signaling by a negative feedback system mainly inducing the suppressor of cytokine signaling 3 (SOCS3), as studied in different cell types [3] . Another pathway involves the direct activation of AMP-activated protein kinase (AMPK) by leptin on muscle, promoting oxidative metabolism [5] . Moreover, Moon et al. have also shown the ability of leptin to activate, in muscle cells, the signaling pathways involving signal transducer and activator of transcription 3 (STAT3), Akt (protein kinase B -PKB) and extracellular signal-regulated kinase 1/2 (ERK1/2) [6] , thus leptin seems to have a profound effect in muscular cells.
We have conducted previous studies with sequential models of gene expression analyses in vitro (analyzing the effects on muscle cells of free fatty acids either alone or in combination with exercise mimetics) and in vivo in soleus and gastrocnemius muscles (with fasting and refeeding) [7, 8] where we have highlighted the rapid modulation of gene expression levels of key metabolic/signaling genes such as peroxisome proliferator activated receptor (PPAR) gamma co-activator 1α (PGC1α), uncoupling protein (UCP) 3, pyruvate dehydrogenase kinase 4 (PDK4) and interleukin (IL) 6. Interestingly, one important signal whose levels change in a time sequential mode with fasting and refeeding is circulating leptin [9] , which is a primary signal (its decrease) in starvation [10] .
Under this prospect, we aimed to shed light on the direct time-and dose-dependent effects of physiological concentrations of leptin in muscle cells in the expression of the above mentioned genes, and other key genes in energy metabolism and glucose/lipid fuel partition, as well as in the two main ILs (6 and 15) produced by muscle (recognized as myokines [11, 12] ).
Along these lines, the nuclear receptors PPARs (α,β/δ and γ) are able to regulate energy metabolism, and have a crucial role controlling the partition of nutrients (such as glucose and lipids) as metabolic fuels [13, 14] . Both PPARα and β/δ are key in controlling fatty acid oxidation, and although PPAR β/δ shows greater expression in muscle, both are important in the control of muscle cell energy metabolism [13, 14] . On the other hand, PPARγ is abundantly expressed in adipose tissue where is mainly involved in energy storage, although it is also involved in the stimulation of fatty acid oxidation in skeletal muscle [15] .
With respect to PGCs, PGC1α is the best known and binds PPARγ and other transcription factors, while PGC1β is also a co-activator of the PGC family but less known [16] . Both PGCs are involved in the promotion and control of mitochondrial biogenesis and respiratory metabolism [17] . In skeletal muscle, PGC1α is known to have key functions in fatty acid oxidation, lipogenesis, myokine secretion, glucose uptake, fiber switching, etc. [16] .
Regarding the uncoupling proteins UCP2 and UCP3, their expression seems to be controlled, among others, by PPARs [18] . UCP2 and 3 seem to be mainly involved in the protection of mitochondria by the mitigation of ROS production and/or, especially in the case of UCP3, in the export of fatty acid anions during lipid oversupply, protecting mitochondria from lipotoxicity [19, 20] . Concerning PDK4, it is crucial in fuel selection since it inactivates the pyruvate dehydrogenase -PDH-complex [14] . 
Cellular Physiology and Biochemistry
We have also studied the expression of: the Insulin receptor (InsR) (taking into account the crosstalk between leptin and insulin signaling [3] ), the insulin regulated glucose transporter GLUT4 [21] , and the muscle isoform of carnitine palmitoyl transferase 1 (mCPT1 or CPT1B) (rate-limiting enzyme involved the transport of fatty acids to the mitochondria for their oxidation [22] ). Moreover, the expression of both PDK4 and mCPT1 is known to be regulated by PPARα [14] .
Last, but not least, IL6 and IL15 are signal molecules produced and/or secreted by muscle [11, 23] . Muscle IL6 has been related to physical activity, muscle-adipose tissue crosstalk, the promotion of glucose-sensitizing and anti-inflammatory effects, etc; in fact it shares some roles with leptin in muscle like the capacity to activate AMPK [12] .
We performed a time-sequential and dose-dependent model (similar to previous works [7, 8] ) of differentiated cultured muscle cells (C2C12) treated with leptin to characterize its effects on the expression of the strategic molecules described above. We describe here that leptin causes a rapid response of myocytes by inducing the expression of key genes involved in metabolic and fuel control (especially those codifying PGC1α, mCPT1, UCP3 and PDK4) and of the myokine IL6.
Materials and Methods
Cell culture and leptin treatments Mouse C2C12 myoblasts (ATCC, Promochem, Barcelona, Spain) were used. Cells were grown in DMEM (containing 4500 mg/L (high) glucose) (Sigma Aldrich, Madrid, Spain) supplemented with 10% Foetal Bovine Serum (Gibco-Invitrogen, Barcelona, Spain), antibiotics (50 IU/ml penicillin, 50 μg/ml streptomycin), 4 mM L-glutamine and sodium pyruvate 1 mM (Sigma Aldrich) (growth medium) in 5% CO 2 at 37°C in a humidified chamber. When the cells were 70-80% confluent, they were induced to differentiate into myotubes by placing them in a low-serum differentiation medium (DMEM with antibiotics, glutamine and 2% horse serum) for ten days. The differentiated myotubes were used for experiments. C2C12 myotubes were treated with DMEM (control) or leptin (5, 10, and 50ng/ml in DMEM) for 0.5, 3, 6, 12 and 24 h. The recombinant murine leptin came from PeproTech (PeproTech, London, England). In our experimental design, we monitored the time-course changes in gene expression in both leptin-treated and non-treated cells (to have suitable time-controls) and the results given in the figures showing gene expression are given as a percentage increase of each treated time point with respect to their respective time controls; by doing this, we make sure that the observed differences are due to the treatment performed and not to timedependent oscillations in gene expression in the cultured cells.
RNA isolation
After adequate treatments, total RNA was extracted from C2C12 cells by Tripure Reagent (Roche Diagnostics GmbH, Mannheim, Germany) according to the manufacturer's instructions. Isolated RNA was quantified using the NanoDrop ND-1000 spectrophotometer (NadroDrop Technologies, Inc., Wilmington, DE, USA) and its integrity confirmed using agarose gel electrophoresis, and stored at -80ºC.
Protein isolation and quantification
Protein samples from C2C12 cells were extracted from phenolic Tripure phase by adding 300 μl of ethanol 100% at 4° C and agitating (by inverting) for 1 min. Then, they were centrifuged at 2000g for 5 min at 4° C. Supernatant was collected and 1.5 ml of isopropanol was added to each sample and mixed by inversion; after an incubation of 10', the samples were centrifuged at 12000 g for 10' at 4° C, keeping the pellet. After three washing steps with 2 ml of Guanidine-HCl 0.3 M in ethanol 95% and centrifugation at 7500g for 5min at 4° C, 2 ml of Ethanol 100% was added to the pellet, with a following incubation for 20' at room temperature and centrifugation at 7500g for 5' at 4° C. The final pellet was dried by evaporation and was dissolved in 150 μl SDS 2% and stored at -20°C until Western blot analysis. Total protein amount was quantified by the BCA™ Protein Assay Kit (Pierce, Rockford, IL, USA). 
Real-time quantitative PCR analysis
Real-time polymerase chain reaction (PCR) was used to measure mRNA expression levels of PGC1α, PGC1β, UCP2, UCP3, PPARα, PPARβ/δ, PPARγ, PDK4, OB-Rb, InsR, GLUT4, IL6, IL15, muscle isoform mCPT1, and SOCS3 in C2C12 cells. 0.25μg of total RNA (in a final volume of 12.5μl) was denatured at 65°C for 10 min and then reverse transcribed to cDNA using murine leukemia virus reverse transcriptase (Applied Biosystems, Madrid, Spain) at 20°C for 15 min, 42ºC for 30 min, with a final step of 5 min at 95ºC in an Applied Biosystems 2720 Thermal Cycler. Each PCR done afterwards was performed with diluted (1/5) cDNA template, forward and reverse primers (1 μM each) and Power SYBER GreenPCRMaster Mix (Applied Biosystems).
Real-time PCR was performed using the Applied Biosystems StepOnePlusTM Real-Time PCR Systems with the following profile: 10 min at 95°C, followed by a total of 40 temperature cycles (15 s at 95°C and 1 min at 60°C). To verify the purity of the products, a melting curve was produced after each run according to the manufacturer's instructions. The threshold (Ct) values were determined by the instrument's software (StepOne Software version 2.1, Applied Biosystems). 18S ribosomal RNA was used as reference gene. All primers were obtained from Sigma Genosys (Sigma Aldrich). Primers for the different genes are described in Table 1 .
Western blotting
The amount of PGC1α in C2C12 cells (treated with leptin 50ng/ml for 3, 12 and 24h) was determined by Western blot analysis. 40μg of total protein was solubilized and boiled for 3 min in Laemmli sample buffer containing 5% 2-mercaptoethanol. Then, total protein was fractionated by SDS-PAGE (10% polyacrylamide) and electrotransferred onto a nitrocellulose membrane (Bio-Rad, Madrid, Spain). After blocking in Odyssey blocking buffer (LI-COR, Lincoln, Nebraska, USA), the membrane was incubated with the primary rabbit polyclonal anti-PGC1α H-300 antibody (Santa Cruz Biotechnology, Inc., Santa Cruz, CA), diluted 1:1000 for 1h at room temperature (RT), and then washed 3x5' with TBS-Tween; afterwards, the membrane was incubated with the primary mouse monoclonal anti-β-actin antibody (Cell Signaling Technology, Inc., Danvers, MA, USA) diluted 1:1000 for 30' at RT, washed again 3 times with TBS-Tween (15' and 2x5') and then incubated with the corresponding infrared-dyed secondary IgG antibodies (LI-COR Biosciences) diluted 1:10.000. The membrane was scanned by using the Odyssey Infrared Imaging System (LI-COR Biosciences).
Statistical analysis
The data represent the mean ± SEM of three separate experiments performed in duplicate. The results are given as a percentage increase of each treated time point with respect to their respective time controls. Differences between treated groups and their corresponding time-controls were assessed by Student's t test. Leptin 50 ng/ml ** Fig. 1 . Time-course mRNA expression of transcriptional activators and co-activators in response to leptin (50ng/ml) in C2C12 muscle cells. mRNA expression is referred to the matching time-control for each time point studied and given as a percentage increase with respect to the corresponding control. Data represent the mean ± SEM of three separate experiments performed in duplicate. Student's t test: **significant differences at p< 0.05, *significant differences at p< 0.1.
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PGC1α Moreover, the early increase in PGC1α mRNA expression was later accompanied by a gradual increase in PGC1α protein levels, which were significantly elevated (almost double) after 24h of treatment with leptin 50ng/ml (Fig. 2) .
Effects of leptin on the expression of key molecules in fuel selection and use
The greatest effect of 50ng/ml leptin treatment was observed for UCP3 mRNA levels, which were elevated relatively soon after the beginning of the treatment (3h), accompanied with a significant elevation of mCPT1 mRNA levels at the same time point (see Fig. 3A ) and a tendency to induce PDK4 mRNA levels (significant at the p<0.1 level). On the other hand, there was a descent of the same mCPT1 mRNA after 24h of treatment, and of UCP2 mRNA levels after 6h of treatment. Moreover, the main effect of leptin on PDK4 expression was to induce a significant decrease in its mRNA levels after 24h of treatment at the concentration of 50ng/ml (Fig. 3A) , and curiously the effect was more marked with a lower concentration of leptin (10ng/ml) with which there was a significant and progressive decrease of PDK4 expression from 6h of treatment onwards (Fig. 3B) . No effects were observed for GLUT4 mRNA expression.
Effects of leptin on the expression of insulin and leptin receptors and the suppressor of cytokine signaling SOCS3
Leptin treatment caused a significant effect of induction in the expression of its receptor (OB-Rb) at 3h of treatment, both similarly seen with the treatments of 10ng/ml (266.5±153.3% increase, p<0.05) and 50ng/ml (Fig. 4, significant at p<0.1) , without effects on SOCS3 expression. On the other hand, leptin treatment caused a dual contrary effect on InsR mRNA expression, by inducing it after 3h of treatment when given at a concentration of 50ng/ml (Fig. 4) and by decreasing its mRNA levels after 12h when given at a concentration of 10ng/ml (-34.9±4.9% decrease, p<0.05). Student's t test: **significant differences at p< 0.05, *significant differences at p< 0.1.
Cellular Physiology and Biochemistry Cellular Physiology and Biochemistry

Effects of leptin on the expression of the myokines IL6 and IL15
Although leptin showed a little yet significant effect on IL15 mRNA expression early on (30') by inducing it when given at a concentration of 50ng/ml (Fig. 5) , the greatest effect was observed for IL6 expression, which was also significantly induced by 50ng/ml of leptin treatment very early on (at 30' -p<0.05 -and maintained at 3h -p<0.1) but decreased afterwards (Fig. 5) , and even with a significant effect on IL6 mRNA expression induction with the treatment of leptin 10ng/ml after 3h (89.5±46% increase, p<0.05) and 6h (96.6±33.1% increase, p<0.1).
Discussion
The results of our study show that leptin administration in differentiated myotubes has a rapid effect on the expression of different strategic molecules related to the control of energy metabolism, particularly PGC1α, mCPT1, PDK4, UCP3 and IL6. The tested concentrations of leptin are within physiological range in the circulation/plasma; e.g. concentrations in Student's t test: **significant differences at p< 0.05, *significant differences at p< 0.1.
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Cellular Physiology and Biochemistry Cellular Physiology and Biochemistry serum of NMRI non-obese control mice (which are approx. between 20-50ng/ml in 4-6 month-old animals) [24] . The induction of the expression at mRNA level of the master transcriptional co-activator PGC1α is transient but rapid and evident as early as 30' after leptin administration, and is even more elevated after 3h (Fig. 1) , and thereafter reflected in the increase of PGC1α protein levels (gradually increasing and becoming significantly greater after 24h) (Fig. 2) . Regarding this, two important questions must be outlined: 1) due to the key functions of PGC1α, this effect may be directly related to other transcriptional changes observed in this work and the rapid response may suggest that PGC1α may be a key molecule orchestrating ulterior effects of leptin in the cells, and 2) how can the expression of PGC1α when leptin acts on muscle cells be increased. With respect to the first question, this is not the first time we have observed a rapid transient increase of PGC1α expression which may be related with posterior transcriptional changes facing a metabolic challenge; we have reported that sequential fasting in rat muscle in vivo and FFA (oleic/linoleic) or adrenaline treatment of C2C12 cells cause a peak of increased PGC1α mRNA levels after 4h (fasting) or 3h (FFA or adrenaline), thereafter returning to basal levels in all cases [7, 8] . To address the second question, it is important to note that in muscle cells leptin is able to activate the catalytic α2 subunit of AMPK promoting its kinase activity on downstream molecules [5] . In the literature, the activation of AMPK has been reported to promote the activation of the deacetylase SIRT1 (Sirtuin 1) which is believed, according to one of the proposed theories, to activate PGC1α protein by deacetylation [25] ; it has been reported that direct phosphorylation of PGC1α by AMPK also promotes the activity of the transcriptional coactivator [26] ; moreover, activated AMPK has been suggested to increase PGC1α expression in muscle [26] [27] [28] and such an effect would probably be achieved through an auto-regulatory loop of PGC1α on its own promoter [29, 30] . Thus, following this reasoning, a good explanation for the induction of PGC1α expression observed here would be the activation of AMPK by leptin treatment. Nevertheless, the answer may not be that simple. Although Jäger et al. [26] observed an increase in PGC1α expression with AICAR (precursor of an AMP mimetic able to directly activate AMPK) in primary myotubes after 16h of treatment, and other works have shown that activation of AMPK with exercise or AICAR increases the expression of PGC1α (although in in vivo models) [27, 28] , we have previously described that the treatment of C2C12 differentiated myotubes (following again a similar sequential model to the one used here) with AICAR alone is not able to induce PGC1α expression at all, but rather has to be accompanied by other signals (such as adrenaline or free fatty acids) acting at the same time [8] . Therefore, the clear, direct (on muscle cells), early effect of leptin on PGC1α expression reported here is, to our knowledge, something new and the possible mechanism leading to it would be somewhat complex, involving other effects of leptin on muscle cells beyond its capacity to stimulate AMPK activity. More research to decipher the possible pathways involved would be of interest, such as the study of the implication of the JAK/STAT, Akt and ERK signaling pathways, known to be activated by leptin in muscle cells [3, 6] . With respect to the other PGC1 family member studied, PGC1β, we have only observed a slight tendency to induce its expression after 12h of leptin treatment, and therefore a possible impact on oxidative capacity mediated by this co-activator may be possible, although from the results shown here it seems that the leptin effect may be more significant through PGC1α induction. At transcriptional level, the present results show that for PPARs the main effects are the slight tendency to early induce PPARα and PPARγ mRNA levels (Fig. 1) , which may have an impact on the metabolic capacity of the muscle cells (both are involved in the stimulation of fatty acid oxidation in skeletal muscle [13] [14] [15] ). We have not addressed the direct activation of the transcriptional activity of these nuclear receptors, but it is feasible to think that their slightly higher expression levels, together with the greater expression of PGC1α, would prepare the cells treated with leptin to have an enhanced oxidative capacity. In fact other studies have reported that leptin treatment in muscle cells activate the DNA binding activity of the three PPARs [31] , and the expression of PPARα by inducing the nuclear translocation of the α2 subunit of AMPK [32] , in line with this same idea of the important impact of leptin on gene expression and oxidative capacity in muscle cells.
The results obtained for the effect of leptin in mCPT1, PDK4 and UCP3 (Fig. 3 ) expression also support the idea that leptin treatment in muscle cells would have a major impact inducing oxidative capacity and managing the fuel substrate to be mainly used. In this sense, although long treatment (24h) with leptin results in a down-regulation of mCPT1, at early stages (after 3h of treatment in this case), it causes an up-regulation, which may be translated into a higher capacity to derive fatty acids for their oxidation in the mitochondria [22] . This result is accompanied by the marked induction of UCP3 expression relatively early on (at 3h), which is suggested to be involved in the export of fatty acid anions during lipid oversupply protecting mitochondria from lipotoxicity [19, 20] . Thus, the expressioninducing early effect of leptin in mCPT1 and UCP3 (which is more specific to muscle cells than UCP2 [33] ) would be along the same lines of preparing the muscle cells for greater oxidative metabolism of lipids, whereas UCP2 expression would even be slightly reduced by leptin (at 6h), suggesting a significantly different regulation between both UCPs by leptin in muscle cells. Contrary to our results, the induction of UCP2 expression (mRNA levels) with leptin in a similar serum-free model in C2C12 myotubes has been previously described, but significantly higher concentrations of leptin were used [34] . On the other hand, PDK4 expression ( Fig. 3A-B ) is progressively and markedly down regulated by leptin at 10ng/ml and less markedly with the greater 50ng/ml leptin concentration (only evident after 24h treatment) but with a tendency to be up-regulated at 3h (p<0.1). Since PDK4 phosphorylates and inhibits the PDH complex and is therefore involved in fuel selection (inhibiting the whole oxidation of glucose) [35] , these results together with the induction of PGC1α, PPARs, mCPT1 and UCP3 suggest that leptin treatment would prepare the muscle cell to increase both lipid and glucose oxidation. The time-course design of this study allows us to go into further detail: in the short-term (3h) there is a significant induction of mCPT1 expression and a tendency to up-regulate PDK4 mRNA, which would be in line with preparing the cell for a preference to burn lipids rather than to completely oxidize glucose (preserving the 3C compounds derived from glycolysis), while in the long-term (24h) there is a significant downregulation of both PDK4 mRNA and mCPT1, which may allow the cell to derive the selection of fuel to increased oxidation of glucose and less marked (compared to the first hours of induction) oxidation of lipids. However, this does not mean that whole lipid oxidation may be decreased, since Akasaka et al. [34] showed in C2C12 myotubes that palmitate oxidation is increased with respect to control cells after 24h of leptin treatment (although with a high concentration of leptin). This idea opens the possibility of a putative dual role of leptin in fuel selection in muscle cells, which would also deserve additional studies addressing not only expression at mRNA level. Moreover, with respect to PDK4 mRNA down-regulation, we have also observed in previous experiments (unpublished data) that treatment of C2C12 cells with AICAR also causes a marked reduction in PDK4 mRNA levels, and other authors [36] have also described a decrease of PDK4 expression with AICAR in primary human myotubes. To our knowledge, this is the first time that the inhibitory effect of leptin on PDK4 in muscle cells has been described and, in addition, given the effect of AICAR on it, we can hypothesize that the effect of leptin on PDK4 levels may be mediated, at least in part, by AMPK activation. Likewise, in our previous work analyzing the effect of sequential fasting and refeeding in rat soleus (highly oxidative) and gastrocnemius (mixed oxidative/glycolytic muscle) [7] we reported a similar (especially in gastrocnemius), but inverse (by increasing its expression) time-dependent pattern of response of PDK4 expression to fasting (when leptin falls) with a partial reversion of short refeeding, which may be associated with changes in circulating leptin [9] , which follows a similar time-pattern of changes; i.e. there is a sequential increase of gastrocnemius PDK4 expression with 4, 8 and 24h fasting and a sequential decrease of circulating leptin levels (same hours) with a partial recovery of both with 3h refeeding [7, 9] . Altogether, these results suggest leptin may be a crucial hormone in regulating PDK4 expression (and thus fuel partitioning) in muscle cells.
In our work, we also wanted to address the effect of leptin on muscle cells in promoting or impairing their sensitivity to leptin and insulin (Fig. 4) . Although there is an induction of InsR expression in the short term (3h) with leptin 50ng/ml, an opposite effect after 12h Only with the parameters studied here, it is difficult to explain the dose-time-dependent effect of leptin on InsR expression, but it may have a possible impact on insulin receptor expression to modulate/ adjust insulin sensitivity. Contrarily, in terms of the expression of the long form of the leptin receptor (OB-Rb) it seems that the effect of the hormone would be to induce its expression (more markedly with the treatment of 10ng/ml, see results section), without effects on SOCS3 expression, thus suggesting a possible slight effect of leptin inducing a greater sensitivity to its own effects, at least with not really prolonged treatments (the longest treatment here lasts 24h). A similar effect on OB-Rb expression was observed by Maroni et al. [37] with short leptin treatment (30'), involving the signaling proteins Sam68 and ERKs. Although we do not observe significant changes of leptin treatment on SOCS3 expression, other authors [38] have described the induction of SOCS3 expression by leptin in vitro; nevertheless, this discrepancy can be due to various factors such as a different cell line (L6 myocites), different medium conditions and especially significantly higher concentration of leptin. It must be outlined that in our experimental model we aimed to characterize the effect of relatively low/physiological concentrations of leptin.
With respect to the influence on key myokines, we addressed the study of leptin effect on IL6 an IL15 expression. Both IL6 and IL15 mRNA were up-regulated by leptin (50ng/ ml) treatment after 30', but with a more marked effect on IL6 mRNA (Fig. 5) , which was also up-regulated with the concentration of 10ng/ml (see results section). We have not found previous similar studies of the effect of leptin on IL6 or IL15 expression in muscle cells and it is interesting to note that if leptin has the ability to regulate their expression it may have important non-described effects on muscle cells. Both ILs have been related to the positive effects of exercise, and seem to regulate muscle growth or metabolism [12] . IL6 has been especially related to the crosstalk with adipose tissue and the promotion of insulin sensitivity and to the crosstalk with leptin signaling, and is also able to activate AMPK [12] . Therefore, since leptin shows a rapid impact on IL expression, it may have an important influence on muscle cell physiology by inducing ILs, especially IL6 expression, and by further activating AMPK.
In summary, we show here that leptin treatment has profound effects on muscle cell gene expression, with a rapid response of key genes involved in nutrient partition and oxidation and in other signaling pathways. Moreover, we have previously shown in in vivo and in vitro models [7, 8] that some of the key genes that show here the most marked and rapid response to leptin, such as the ones encoding PGC1α, UCP3, PDK4 and IL6, also rapid and markedly respond to other physiological conditions such as fasting, refeeding and free fatty acid oversupply, thus underpinning the possible crucial importance of these genes in muscle cell physiology, which may be therapeutic targets for conditions of muscle metabolism malfunctioning such as obesity, diabetes and sedentary lifestyle.
